In order to develop a Pkd1‐linked model of ADPKD that recapitulates the key pathological and biochemical features of the disease within a timeframe suitable for therapeutic testing, we tested the effects of altering the timing and dose of tamoxifen in an inducible Pkd1 cKO mouse model. Here, PKD1 is linked to autosomal dominant polycystic kidney disease.